机构:[1]State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China四川大学华西医院[2]Horae Gene Therapy Center, University of Massachusetts, Medical School, Worcester, MA, USA[3]Microbiology and Physiological Systems, University of Massachusetts, Medical School, Worcester, MA, USA[4]Fornax Biotech, Worcester, MA, USA[5]Biobank, West China Hospital, Sichuan University, Chengdu, China四川大学华西医院[6]Department of Thoracic Oncology and State Key Laboratory of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, China四川大学华西医院[7]Pathology Department and State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China四川大学华西医院[8]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China四川大学华西医院[9]Department of Liver Surgery, West China Hospital, Sichuan University, Chengdu, China四川大学华西医院[10]Department of Gastrointestinal Surgery and Laboratory of Gastric Cancer, West China Hospital, Sichuan University, Chengdu, China四川大学华西医院[11]Pediatrics, University of Massachusetts, Medical School, Worcester, MA, USA
Recombinant adeno-associated viruses (rAAVs) are well-established vectors for delivering therapeutic genes. However, previous reports have suggested that wild-type AAV is linked to hepatocellular carcinoma, raising concern with the safety of rAAVs. In addition, a recent long-term follow-up study in canines, which received rAAVs for factor VIII gene therapy, demonstrated vector integration into the genome of liver cells, reviving the uncertainty between AAV and cancer. To further explore this relationship, we performed large-scale molecular epidemiology of AAV in resected tumor samples and non-lesion tissues collected from 413 patients, reflecting nine carcinoma types: breast carcinoma, rectal cancer, pancreas carcinoma, brain tumor, hepatoid adenocarcinoma, hepatocellular carcinoma, gastric carcinoma, lung squamous, and adenocarcinoma. We found that over 80% of patients were AAV-positive among all nine types of carcinoma examined. Importantly, the AAV sequences detected in patient-matched tumor and adjacent non-lesion tissues showed no significant difference in incidence, abundance, and variation. In addition, no specific AAV sequences predominated in tumor samples. Our data shows that AAV genomes are equally abundant in tumors and adjacent normal tissues, but lack clonality. The finding critically adds to the epidemiological profile of AAV in humans, and provides insights that may assist rAAV-based clinical studies and gene therapy strategies.
基金:
This work was supported by grants from the University
ofMassachusetts Medical School (an internal grant) and by the NIH
(R01NS076991-01, P01AI100263-01, P01HL131471-02, R01AI121135,
UG3HL147367-01, R01HL097088, and U19AI149646-01).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类|1 区医学
小类|1 区生化与分子生物学1 区肿瘤学1 区遗传学2 区细胞生物学
最新[2023]版:
大类|1 区医学
小类|1 区生化与分子生物学1 区遗传学2 区细胞生物学2 区肿瘤学
第一作者:
第一作者机构:[1]State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
共同第一作者:
通讯作者:
通讯机构:[2]Horae Gene Therapy Center, University of Massachusetts, Medical School, Worcester, MA, USA[3]Microbiology and Physiological Systems, University of Massachusetts, Medical School, Worcester, MA, USA[11]Pediatrics, University of Massachusetts, Medical School, Worcester, MA, USA
推荐引用方式(GB/T 7714):
Wanru Qin,Guangchao Xu,Phillip W. L. Tai,et al.Large-scale molecular epidemiological analysis of AAV in a cancer patient population.[J].Oncogene.2021,40(17):3060-3071.doi:10.1038/s41388-021-01725-5.
APA:
Wanru Qin,Guangchao Xu,Phillip W. L. Tai,Chunmei Wang,Li Luo...&Guangping Gao.(2021).Large-scale molecular epidemiological analysis of AAV in a cancer patient population..Oncogene,40,(17)
MLA:
Wanru Qin,et al."Large-scale molecular epidemiological analysis of AAV in a cancer patient population.".Oncogene 40..17(2021):3060-3071